Radiopharm Theranostics RADX
NASDAQ RADX
$1.55 -0.07 (-4.49%)
As of: Oct 1, 2026 · 12:27 PM EDT

Radiopharm Theranostics (RADX) Gross Profit (2024 - 2026)

Updated

Radiopharm Theranostics' Gross Profit came in at $1,789 for FY2026 (year ended Jun 30, 2026), down 95.4% from $39,276 in FY2025.

Analysis

Radiopharm Theranostics (RADX) Gross Profit (2024 - 2026) Analysis & Trends

Going back to FY2023, Radiopharm Theranostics' Gross Profit data covers 4 fiscal years.

  • Gross Profit carries a three-year compound annual growth rate of -81.7% (FY2023 to FY2026).
  • Per Business Quant, earlier fiscal years put Gross Profit at $39,276 in FY2025 (-86.9%), $299,228 in FY2024 (+2.3%) and $292,359 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 186,835.86
Jun 30, 2025 25,153.65
Jun 30, 2024 197,198.58
API Access

Radiopharm Theranostics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=RADX&period=max&api_key=YOUR_API_KEY